Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.

Selected Research

Estimating the Impact of Medical Innovation
Mark Duggan, William N. Evans, NBER Working Paper No. 11109, 2-1-05

A decade ago (1995), AIDS was the eighth-leading cause of death among men, and the single greatest killer of men ages 25-44.

Three years later, the number of AIDS deaths plunged by nearly 70 percent. The authors use data from 1993-2003 to create “a sample of more than 10,000 Medicaid recipients from the state of California” diagnosed with HIV to gauge the impact of new antiretroviral treatments (ARVs) on declining AIDS mortality.

Their conclusions “demonstrate that the increase in the use of the four [ARV] drugs approved by the FDA in late 1995 and early 1996 was responsible for more than 90 percent of the drop in the mortality rate from 1995 to 1998.”

They conclude that although the new drugs tripled lifetime Medicaid spending for these patients, “the new treatments were cost effective, with the average additional cost in Medicaid spending per life-year saved equal to $23,000.”

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000